Near-Infrared Fluorescence Imaging System Market size was valued at USD 1.25 billion in 2024 and is likely to cross USD 5.52 billion by 2037, expanding at more than 12.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of near-infrared fluorescence imaging system is assessed at USD 1.37 billion.
The growth of the market can be attributed to the worldwide growing counts for various types of surgical procedures. For instance, a striking 311 million major surgeries are carried out annually throughout the world.
The near-infrared fluorescence (NIRF) imaging system is a recently developed clinical technique that transmits near-infrared excitation light to observe blood and lymph flow underneath the tissue surface while giving surgeons high - precision images of the targeted tissue. Furthermore, the worldwide increase in robotics surgeries are also fueling the demand of these imaging systems as the adoption of near-infrared fluorescence imaging system during robotic surgeries has a number of benefits, including successful outcomes, increased efficiency, and safety. For instance, each year, more than 610.000 robot-assisted procedures are performed.
Growth Drivers
Rapidly Growing Geriatric Population – Growing age brings several types of health issues, i.e., refractive errors, chronic obstructive pulmonary disease, hearing loss, and others. Thus, growing geriatric population is more tend to undergo of numerous types of surgical intrusion, that is fueling the demand of near-infrared fluorescence imaging system. As per the data released by the World Health Organization, in 2020, the proportion of the population aged 60 and up was increased from 1 billion to 1.4 billion.
Escalation in Cancer – Growing occurrence of several types of cancer is up surging the demand of early cancer detection and surgeries as well. It is possible to see, remove, and treat malignant tissue using fluorescence imaging techniques. As per the World Health Organization, nearly 10 million people were died from cancer worldwide in 2020.
Significant Increase in Reconstructive Surgeries - Reconstructive surgery corrects defects, i.e., birth, disease-related, and injury-related that has permanently affected some part of a person’s body. Currently, huge number of people have been going under reconstructive surgeries to fix out such condition. For instance, in 2020, nearly 6.5 million reconstructive surgical procedures were performed in the United States.
Upsurge in Gastrointestinal Disorders - Gastrointestinal disorders affect the GI tract, which expanded from the mouth to the anus and result in irritable bowel syndrome, constipation, bloating and so on. Such digestive health condition requires an appropriate treatment. It was observed that till 2021, 4 out of every 10 adults in the world had functional gastrointestinal disorders of severe forms.
Growth in Healthcare Spending – As per the World Bank, as compared to 2018, worldwide healthcare expenditure increased to 9.83% in 2019. Higher expenditure on healthcare indicates the deployment of better medical services and improved devices for the treatment.
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
12.1% |
|
Base Year Market Size (2024) |
USD 1.25 billion |
|
Forecast Year Market Size (2037) |
USD 5.52 billion |
|
Regional Scope |
|
Indication (Gastrointestinal, Cardiovascular, Cancer, Plastic/Reconstructive Surgeries)
The global near-infrared fluorescence imaging system market is segmented and analyzed for demand and supply by indication into gastrointestinal, cardiovascular, cancer, plastic/reconstructive surgeries, and others Out of the five indication, the cancer segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising prevalence of numerous types of cancer on a worldwide scale. As per the World Health Organization, cancer is one of the primary reasons of death globally. The South-East Asia Region reported approximately 2.2 million new cases and 1.4 million cancer-related deaths in 2020, accounting for more than 1 in 10 of all deaths in the region.
End-user (Hospitals & Clinics, Research Labs, Pharmaceutical Companies)
The global near-infrared fluorescence imaging system market is also segmented and analyzed for demand and supply by end-user into hospitals & clinics, research labs, and pharmaceutical companies. Amongst these three segments, the hospital & clinics segment is expected to garner a significant share. The growth of the segment is expected on the account of rising demand for near-infrared fluorescence imaging system in the hospitals and clinics and growing demand for medical imaging equipment services for the diagnosis of the patient.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Light Source |
|
|
By Application |
|
|
By Indication |
|
|
By End-User |
|
North American Market Forecast
North America industry is expected to dominate majority revenue share of 39% by 2037. The growth of the market can be attributed majorly to the rapid adoption of technically advanced medical devices, increasing number of cancer cases, rise in the count of surgical procedures, and increasing disposable income in the region. It is observed that, approximately 41 to 52 million surgical procedures are performed each year in the United States.
APAC Market Statistics
The Asia Pacific near-infrared fluorescence imaging system market, amongst the market in all the other regions, is projected to hold the notable market share by the end of 2037. The growth of the market is credited to rising cases of cancer in the region and higher investment in medical devices. In 2022, there were around 5 million cancer cases in China, and nearly 3 million people died due to it. Moreover, lung cancer is the leading cause of death cancer death in the country. Furthermore, the "Promotion of Medical Device Parks" program from FY21 to FY25 was approved by the Department of Pharmaceuticals in August 2022 with a total financial investment of around USD 50 million, with a maximum support under the program of nearly USD 12 million for each Medical Device Park.
PerkinElmer, Inc. announced the launch of a preclinical ultrasound imaging system that is designed to accelerate non-invasive research and drug development studies on cancer, liver diseases, cardiology, and more.
Medtronic plc announced that FDA has permitted 510(k) clearance to its PillCam Small Bowel 3 @HOME systems for remote endoscopy procedures, which provides telehealth options for direct visualization and monitoring of the small bowel.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?